All AbMole products are for research use only, cannot be used for human consumption.
NVP-AEW541 is more selective and shows 27-fold more potent than InsR at the cellular level. NVP-AEW541 suppresses the IGF-I-mediated survival, soft agar and proliferation of MCF-7 cells with IC50 of 0.162 μM, 0.105 μM and 1.64 μM, respectively. NVP-AEW541 also reduces the level of phospho-IGF-1R and phospho-PKB in NWT-21 cells.NVP-AEW541 inhibits IGF-I-mediated receptor activation and downstream signaling. Ewing's sarcoma cells were generally found to be more sensitive to the effects of this compound compared with rhabdomyosarcoma and osteosarcoma, in agreement with the high dependency of this neoplasm to IGF-IR signaling. NVP-AEW541 induced a G1 cell cycle block in all cells tested, whereas apoptosis was observed only in those cells that show a high level of sensitivity. NVP-AEW541 represents a class of selective, small molecule IGF-IR kinase inhibitors with proven in vivo antitumor activity and potential therapeutic application.
 |
Source | PLoS One (2017). Figure 2. NVP-AEW541 |
| Method | western blotting | |
| Cell Lines | MDA-MB-231 and BT-549 cells | |
| Concentrations | 1 μM | |
| Incubation Time | 24 h | |
| Results | Both NVP-AEW541 (1 μM) and rapamycin (10 nM) notably increased the expression level of the autophagy-related protein Beclin-1 and the ratio of LC3-II/LC-I and reduced the level of the selective autophagy substrate p62. |
| Cell Experiment | |
|---|---|
| Cell lines | MCF-7 cells |
| Preparation method | Seeding between 3 × 103 and 6 × 103 cells/well in 96-well plates with a total media volume of 100 μL/well. Adding increasing concentrations of NVP-AEW541 24 hours thereafter in quadruplicate. After 72 hours , fixing cells by addition of 25 μL/well Glutaraldehyde (20%) and incubation for 10 min at RT. Then washing cells 2× with 200 μL/well H2O and adding 100 μL Methylene Blue (0.05%) . After incubation for 10 min at RT, washing cells 3× with 200 μL/well H2O. adding 200 μL/well HCl (3%) , and following incubation for 30 min at RT on a plate shaker, absorbance is measured at 650 nm. |
| Concentrations | ~ 10 μM |
| Incubation time | 72 hours |
| Animal Experiment | |
|---|---|
| Animal models | Female Harlan athymic nude mice weighing 18-25 g with NWT-21 cells |
| Formulation | Dissolved in 25 mM L(+)-tartaric acid |
| Dosages | 20, 30, or 50 mg/kg |
| Administration | Administered via p.o. twice daily |
| Molecular Weight | 439.55 |
| Formula | C27H29N5O |
| CAS Number | 475489-16-8 |
| Solubility (25°C) | DMSO 45 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related IGF-1R Products |
|---|
| GSK1904529A
GSK1904529A selectively inhibits IGF-IR and IR with IC50s of 27 and 25 nmol/L, respectively. GSK1904529A shows poor activity (IC50>1 μM) in 45 other serine/threonine and tyrosine kinases. GSK1904529A exhibits anti-tumor activity. |
| XL228
XL228 is a potent multikinase small-molecule inhibitor of insulin-like growth factor type 1 receptor (IGF1R). |
| OSI-906
OSI-906 (Linsitinib) is a potent, selective, dual ATP-competitive tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR) with IC50 values of 35 nM and 75 nM respectively. |
| BMS-536924
Bms-536924 is an orally active, competitive and selective insulin-like growth factor receptor (IGF-1R) kinase and insulin receptor (IR) inhibitor with IC50 of 100 nM and 73 nM, respectively. It also showed moderate inhibitory activity against Mek, Fak and Lck, but almost no inhibitory activity against Akt1 and MAPK1/2. |
| PQ401
PQ401 is an insulin growth factor-1 receptor (IGF-1R) inhibitor. PQ401 inhibits IGF-I-stimulated IGF-IR autophosphorylation with an IC50 of 12.0 μM in a series of studies in MCF-7 cells. PQ401 is effective at inhibiting IGF-I-stimulated growth of MCF-7 cells (IC50, 6 μM). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
